Features
Proton AI platform for medicinal chemistry
Design-Make-Test cycle acceleration
Molecule design with multi-property optimization
State-of-the-art retrosynthetic analysis and route search
Active learning for data-efficient testing
Proprietary chemistry foundation models
Integration with high-throughput synthesis
Collaborative platform for drug discovery partnerships
Transparent AI with validated real-world partnerships
Predictive AI models for protein-ligand interactions
Generative AI for novel molecule design
Built on Nobel Prize-winning AlphaFold system
Drug Design Engine combining predictive and generative AI
Digital biology simulation at scale
Interdisciplinary team of ML and pharma experts
Rapid iteration through AI-driven drug design engine
Partnership model for large-scale drug development
Collaboration with Novartis and Johnson & Johnson
US operations established in 2025
Series B funding in February 2026
